IOL Chemicals and Pharmaceuticals Limited

IOLCP discloses a scheduled one-on-one investor meeting on September 3, 2026, organized by Phillip Capital. The meeting will discuss past financial results and publicly available information only, wit

IOL Chemicals reported strong Q1 FY27 results with revenue up 37% YoY to ₹756 crore and PAT surging 90% YoY to ₹64.5 crore. Non-ibuprofen API portfolio grew 67% YoY, contributing 43% of pharma revenue